Are you looking to stay up to date with the regulatory landscape in drug manufacturing and discover ways you can improve impurities? Join The Medicine Maker and Hovione on July 15. Find out more

The development, trial, and manufacture of medications will drastically change because of COVID-19. How can you navigate this unprecedented environment while still meeting milestones? Find out more

How do you ensure enrolment and adherence when clinics are closed or have restricted access, trade routes are compromised, and patients are still at home? Find out more

This white paper examines the issue of counterfeit drugs, reviewing the various types produced and the nature and range of the damage they cause. The report then focuses on analytical methods for tackling the problem, in particular the use of X-ray powder diffraction (XRPD). Read More.

This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays. Protein stability and higher order structure is used to assist with biocomparability studies. Read More.

Join PDA every Tuesday and Thursday in June for a webinar series on ATMPs. Connect virtually to hear directly from industry experts and global regulators about the latest hot topics around ATMPs. Join us

Bringing you the science stories that matter as humanity navigates its way through the COVID-19 pandemic. Subscribe now